Purpose: The psychological consequences of genetic testing for mutations among individuals at increased risk of developing melanoma remain unexamined. The present study aimed to explore anticipated emotional, behavioral, cognitive, and familial responses to hypothetical genetic testing for melanoma susceptibility. Methods: Forty semi-structured interviews were undertaken with affected (n=20) and unaffected (n=20) individuals at either high or average risk of developing melanoma due to family history. Results: In-depth thematic analysis revealed that, in response to being identified as a mutation carrier, most participants with a family history anticipated calmly accepting their increased risk; either increasing precaution adoption or maintaining already vigilant behavioral practices; perceiving such information as important and valuable; and communicating genetic test results to family members, despite the acknowledgement of potential difficulties. In response to being identified as a non-carrier, the majority of participants expected to feel relieved; to maintain current precautionary health practices; to still perceive themselves at some risk of developing melanoma; and to be wary of the potential negative behavioral consequences of disclosing such information to family members. Women appeared more likely than men to acknowledge the potential for depression and worry following genetic testing. In contrast, more males than females expected to carry a gene mutation, and viewed their current preventive practices as optimum. Conclusion: Genetic testing for melanoma risk is likely to elicit a complex array of emotional, behavioral, cognitive, and familial responses for both testees and their family members, and these responses are likely to bear subtle differences for males and females.
Similar content being viewed by others
REFERENCES
Abbey, A., Andrews, F., & Halman, L. (1991). Gender’s role in responses to infertility. Psychol Women Quart, 15, 295–316.
Aktan-Collan, K., Haukkala, A., Mecklin, J., Uutela, A., & Kaariainen, H. (2001). Psychological consequences of predictive testing for hereditary non-polyposis colorectal cancer (HNPCC): A prospective follow-up study. Int J Cancer, 93, 608–611.
Armitage, C., & Conner, M. (2001). Efficacy of the theory of planned behaviour: A meta-analytic review. Br J Soc Psychol, 40(4), 471–499.
Armstrong, B. K., & Kricker, A. (2001). The epidemiology of UV induced skin cancer. J Photochem Photobiol B, 63(1–3), 8–18.
Arthey, S., & Clarke, V. (1995). Sun tanning and sun protection:A review of the psychological literature. Soc Sci Med, 40(2), 265–274.
Autier, P., & Dore, J. F. (1998). Influence of sun exposures during childhood and during adulthood on melanoma risk. Int J Cance,r 77(4), 533–537.
Bishop, D., Demenais, F., Goldstein, A., Bergman, W., Newton-Bishop, J., Bressac-dePaillerets, B., et al. (2002). Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Nat Cancer Inst, 94, 894–903.
Botkin, J., Smith, K., Croyle, R., Baty, B., Wylie, J., Dutson, D., et al. (2003). Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet, 118A, 201–209.
Brodersen, N. H., Sutton, S., Goff, S., Hodgson, S. V., & Thomas, H. J. (2004). Anticipated reactions to genetic testing for hereditary non-polyposis colorectal cancer susceptibility. Clin Genet, 66(5), 437–444.
Byng-Hall, J. (1988). Scripts and legends in families and family therapy. Fam Proc, 27, 167–179.
Cannon-Albright, L., Meyer, L., Goldgar, D., Lewis, C., McWhorter, W., Jost, M., et al. (1994). Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res, 54, 6041–6044.
Claes, E., Denayer, L., Evers-Kiebooms, G., Boogaerts, A., & Legius, E. (2004). Predictive testing for hereditary non-polyposis colorectal cancer: Motivation, illness representation, and short-term psychological impact. Pat Educ Counsel, 55, 265–274.
Clarke, V., Williams, T., & Arthey, S. (1997). Skin type and optimistic bias in relation to the sun protection and suntanning behaviors of young adults. J Behav Med, 20(2), 207–222.
Collins, V., Meiser, B., Gaff, C., St John, D., & Halliday, J. (2005). Screening and preventive behaviors one year after predictive genetic testing for hereditary non-polyposis colorectal carcinoma. Cancer, 104(2), 273–281.
Conner, M., & Sparks, P. (1996). The theory of planned behaviour and health behaviours. In M. Conner & P. Norman (Eds.), Predicting health behaviour: research and practice with social cognition models (pp. 121–162). Ballmore, Buckingham: Open University Press.
Croyle, R., Smith, K., Botkin, J., Baty, B., & Nash, J. (1997). Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol, 16(1), 63–72.
Decruyenaere, M., Evers-Kiebooms, G., Welkenhuysen, M., Denayer, L., & Claes, E. (2000). Cognitive representations of breast cancer, emotional distress and preventive health behaviour: A theoretical perspective. Psycho-Oncol, 9, 528–536.
N. Denzin, & Y. Lincoln (Eds.) (1994). Handbook of qualitative research, Dallas, TX: Sage Publications.
Dorval, M., Patenaude, A., Schneider, K., Kieffer, S., DiGianni, L., Kalkbrenner, K., et al. (2000). Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs. J Clin Oncol, 18(10), 2135–2142.
Egan, G. (2002). The skilled helper: A problem-management and opportunity-development approach to helping, 7th edn. Pacific Grove, CA: Brooks/Cole Publishing Company.
Foster, C., Eeles, R., Ardern-Jones, A., Moynihan, C., & Watson, M. (2004). Juggling roles and expectations: Dilemmas faced by women talking to relatives about cancer and genetic testing. Psychol Health, 19(4), 439–455.
Gaff, C., Collins, V., Symes, T., & Halliday, J. (2005). Facilitating family communication about predictive genetic testing: Probands’ perceptions. J Genet Couns, 14(2), 133–140.
Goldstein, A., Falk, R., Fraser, M., Dracopoli, N., Sikorski, R., Clark, W. J., et al. (1998). Sun-related risk factors in melanoma-prone families with CDKN2A mutations. J Nat Cancer Inst, 90(9), 709–711.
Hallowell, N., Ardern-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., et al. (2005). Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: Patterns, priorities and problems. Clin Genet, 67(6), 492–502.
Hayward, N. (2003). Genetics of melanoma predisposition. Oncogene, 22, 3053–3062.
Hill, D., Rassaby, J., & Gardner, G. (1984). Determinants of intentions to take precautions against skin cancer. Comm Health Stud, 8, 33–44.
Holland, E., Schmid, H., Kefford, R., & Mann, G. (1999). CDKN2A (p16INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas. Genes Chromosom Cancer, 25, 339–348.
Jarvinen, H., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L., Peltomaki, P., et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary non-polyposis colorectal cancer. Gastroenterol, 118(5), 829–834.
Keesling, B., & Friedman, H. (1987). Psychosocial factors in sunbathing and sunscreen use. Health Psychol, 6, 477–493.
Kefford, R., & Mann, G. (2003). Is there a role for genetic testing in patients with melanoma? Curr Opin Oncol, 15, 157–161.
Kefford, R., Newton-Bishop, J., Bergman, W., & Tucker, M. (1999). Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the melanoma genetics consortium. J Clin Oncol, 17(10), 3245–3251.
Keller, M., & Henrich, G. (1999). Illness-related distress: Does it mean the same for men and women? Gender aspects in cancer patients’ distress and adjustment. Acta Oncologica, 38, 747–755.
Kenen, R., Ardern-Jones, A., & Eeles, R. (2004). We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer. Psycho-Oncol, 13, 335–345.
Koh, H., Bak, S., Geller, A., Mangione, T., Hingson, R., Levenson, S., et al. (1997). Sunbathing habits and sunscreen use among white adults: Results of a national survey. Am J Pub Health, 87(7), 1214–1217.
Lerman, C., Daly, M., Masny, A., & Balshem, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol, 12(4), 843–850.
Lerman, C., Hughes, C., Croyle, R., Main, D., Durham, C., Snyder, C., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med, 31(1), 75–80.
Lerman, C., Marshall, J., Audrain, J., & Gomez-Caminero, A. (1996a). Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int J Cancer, 69, 58–61.
Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., et al. (1996b). BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA, 275(24), 1885–1892.
Lerman, C., Seay, J., Balshem, A., & Audrain, J. (1995). Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet, 57, 385–392.
Leventhal, H., & Cameron, L. (1987). Behavioural theories and the problem of compliance. Pat Educ Counsel, 10, 117– 138.
Leventhal, H., Diefenbach, M., & Leventhal, E. (1992). Illness cognitions: Using common sense to understand treatment adherence and affect cognition interactions. Cognit Ther Res, 16, 143–163.
Loader, S., Shields, C., & Rowley, P. (2004). Impact of genetic testing for breast-ovarian cancer susceptibility. Genet Test, 8(1), 1–12.
Lodder, L., Frets, P., Trijsburg, R., Meijers-Heijboer, E., Klijn, J., Duivenvoorden, H., et al. (2001). Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet, 98(1), 15–24.
Lodder, L., Frets, P., Trijsburg, R., Meijers-Heijboer, E., Klijn, J., & Niermeijer, M. (2000). Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands. J Med Genet, 37(11), 883–884.
Mahlstedt, P. (1985). The psychological component of infertility. Fertil Steril, 43, 335–346.
McCann, S., Stewin, L., & Short, R. (1991). Sex differences, social desirability, masculinity, and tendency to worry. J Genet Psychol, 152, 295–301.
McDonough, P., & Walters, V. (2001). Gender and health: Reassessing patterns and explanations. Soc Sci Med, 52, 547–559.
Meiser, B., Butow, P., Friedlander, M., Barratt, A., Schnieden, V., Watson, M., et al. (2002). Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer, 38, 2025–2031.
Meiser, B., Collins, V., Warren, R., Gaff, C., St John, D., Young, M., et al. (2004). Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet, 66, 502–511.
Michie, S., McDonald, V., & Marteau, T. (1996). Understanding responses to predictive genetic testing: A grounded theory approach. Psychol Health, 11(4), 455–470.
Miles, M., & Huberman, A. (1994). Qualitative data analysis: An expanded sourcebook. Sage.
Miller, S. M., & Kirsch, N. (1987). Sex differences in cognitive coping with stress. In R. Barnett, L. Biener, & G. Baruch (Eds.), Gender and Stress. pp. 278–307. New York: Free Press,
Palmer, J., Duffy, D., Box, N., Aitken, J., O’Gorman, L., Green, A., et al. (2000). Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype? Am J Human Genet, 66(1), 176–186.
Patton, M. (1990). Qualitative evaluation and research method, 2nd edn. Dallas, TX: Sage Publications.
Ptacek, J., Smith, R., & Dodge, K. (1994). Gender differences in coping with stress: When stressor and appraisals do not differ. Pers Soc Psychol Bull, 20(4), 421–430.
Reichelt, J., Heimdal, K., Moller, P., & Dahl, A. (2004). BRCA1 testing with definitive results: A prospective study of psychological distress in a large clinic-based sample. Familial Cancer, 3, 21–28.
Riedijk, S., de Snoo, F., van Dijk, S., Bergman, W., van Haeringen, A., Silberg, S., et al. (2005). Hereditary melanoma and predictive genetic testing: Why not? Psycho-Oncol, 14, 738–745.
Robinson, J., Rademaker, A., Sylvester, J., & Cook, B. (1997a). Knowledge, attitudes, and behaviors of midwest adolescents. Prev Med, 26, 364–372.
Robinson, J., Rigel, D., & Amonette, R. (1997b). Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol, 37, 179–186.
Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., et al. (2002). Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol, 20(5), 1260–1268.
Schwartz, M., Peshkin, B., Hughes, C., Main, D., Isaacs, C., & Lerman, C. (2002). Impact of BRCA1/BRCA2 mutation testing on psychological distress in a clinic-based sample. J Clin Oncol, 20(2), 514–520.
Sheeran, P. (2002). Intention-behavior relations: A conceptual and empirical review. Eur Rev Soc Psychol, 12, 1–36.
Smith, K., Ellington, L., Chan, A., Croyle, R., & Botkin, J. (2004). Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol Biomark Prev, 13(5), 733–740.
Spence, J., Deaux, K., & Helmreich, R. (1985). Sex roles in contemporary American society. In G. Lindzey & E. Aronson (Eds.), Handbook of social psychology (pp. 149–178). New York: Random House.
Stone, A., & Neale, J. (1984). New measure of daily coping: Development and preliminary results. J Pers Soc Psychol, 46, 892–906.
Struewing, J., Lerman, C., Kase, R., Giambarresi, T., & Tucker, M. (1995). Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomark Prev, 4, 169– 173.
Sutton, S. (1998). Predicting and explaining intentions and behavior: How well are we doing? J Appl Soc Psychol, 28(15), 1317–1338.
Tucker, M., Fraser, M., Goldstein, A., Elder, D., Guerry, D. t., & Organic, S. (1993). The risk of melanoma and other cancers in melanoma-prone families. J Invest Dermatol, 100(3), 350S–355S.
van der Velden, P., Sandkuijl, L., Bergman, W., Pavel, S., van Mourik, L., Frants, R., et al. (2001). Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Human Genet, 69(4), 774– 779.
van Ryn, M., Lytle, L., & Kirscht, J. (1996). A test of the theory of planned behaviour for two health-related practices. J Appl Soc Psychol, 26(10), 871–883.
ACKNOWLEDGMENTS
We very gratefully acknowledge the generosity of our participants in sharing their experiences. We sincerely thank Dr. Michael Hughes, Mrs. Dianne Pilling, Mrs. Helen Schmid, Mrs. Robyn Dalziell, and Mrs. Barbara Peters for their assistance with participant recruitment. Nadine Kasparian is supported by an Australian Postgraduate Award from the University of Sydney and a Gold Star Award from the University of New South Wales. Bettina Meiser is supported by a Career Development Award from The National Health and Medical Research Council of Australia (ID 350989). Phyllis Butow is supported by a Research Fellowship from the National Health and Medical Research Council of Australia (ID 211199). Genetic epidemiology studies of the cohort have been supported by grants of the National Health and Medical Research Council of Australia (ID 107359, 211172), the state anti-cancer councils of New South Wales, Queensland and Victoria, and the US National Institutes of Health (RO1 83115-01A2).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kasparian, N.A., Meiser, B., Butow, P.N. et al. Better the Devil You Know? High-Risk Individuals’ Anticipated Psychological Responses to Genetic Testing for Melanoma Susceptibility. J Genet Counsel 15, 433–447 (2006). https://doi.org/10.1007/s10897-006-9038-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-006-9038-3